Abstract

How could imaging reduce therapy-associated morbidity in rhabdomyosarcoma of the bladder or prostate?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Five-Year Follow-up After Multimodal Treatment Incorporating HDR Brachytherapy for Bladder Prostate Rhabdomyosarcoma in Children
Niklas Pal ... Claes Mercke
International Journal of Radiation Oncology, Biology, Physics | VOL. 113
Niklas Pal, et. al.Niklas Pal ... Claes Mercke
01 Feb 2022
Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: Combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee
Modesto Carli ... Fernando A Ferrer
International Journal of Cancer | VOL. 128
Modesto Carli, et. al.Modesto Carli ... Fernando A Ferrer
11 May 2010
Children with Vesical Rhabdomyosarcoma (RMS) Treated by Partial Cystectomy with Neoadjuvant or Adjuvant Chemotherapy, With or Without Radiotherapy A Report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee
Daniel M Hays ... Eugene Wiener
Journal of Pediatric Hematology/Oncology | VOL. 17
Daniel M Hays, et. al.Daniel M Hays ... Eugene Wiener
01 Feb 1995
Epidemiology and survival outcome of adult kidney, bladder, and prostate rhabdomyosarcoma: A SEER database analysis.
Stephen B Riggs ... Kris E Gaston
Rare tumors | VOL. 12
Stephen B Riggs, et. al.Stephen B Riggs ... Kris E Gaston
01 Jan 2020
View more papers

More From: Future Oncology

Paper Title
Journal
Date
Author
Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USA
Kerigo Ndirangu ... Genevieve Meier
Future Oncology | VOL. -
Kerigo Ndirangu, et. al.Kerigo Ndirangu ... Genevieve Meier
17 May 2024
Unraveling noncoding DNA variants and epimutations: a paradigm shift in hereditary cancer research
Maria Baz Ibrahim ... Etienne Rouleau
Future Oncology | VOL. -
Maria Baz Ibrahim, et. al.Maria Baz Ibrahim ... Etienne Rouleau
09 May 2024
Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B
Satoshi Kobayashi ... Yoshiaki Nakamura
Future Oncology | VOL. -
Satoshi Kobayashi, et. al.Satoshi Kobayashi ... Yoshiaki Nakamura
17 Apr 2024
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study
Beilei Cai ... Teddy Saliba
Future Oncology | VOL. -
Beilei Cai, et. al.Beilei Cai ... Teddy Saliba
17 Apr 2024
View more papers